Investigation on new coronavirus vaccine vaccination situation and
hesitation and analysis of influencing factors in rural areas of Liuzhou,
Guangxi

doi:10.3760/cma.j.issn.1007-1245.2022.12.030

Abstract

Abstract:

Objective　To understand the vaccination rate, hesitation rate, and influencing factors of new coronavirus vaccine among residents in rural areas of Liuzhou, Guangxi, and to provide references for improving the vaccine coverage rate. Methods　From October 10, 2021 to November 10, 2021, a questionnaire survey was conducted on residents in rural areas of Liuzhou, Guangxi by means of Questionnaire Star, analyzing the situation of new coronavirus vaccine vaccination and hesitation among residents in rural areas of Liuzhou, Guangxi. Univariate analysis was conducted on the demographic data and multivariate logistic regression analysis was conducted on related factors affecting vaccine hesitation, factors with odds ratio (OR) >1 and 95% confidence interval (95%CI) >1 were the risk factors for vaccine hesitation. χ² test was used for the count data. Results　A total of 1 033 questionnaires were received. Among the 1 033 respondents, 532 cases (51.5%) were males and 501 cases (48.5%) were females, aged (55.2±18.7) years. Among the 1 033 residents surveyed on vaccination and hesitance in Liuzhou, Guangxi, 1,023 residents (99.0%) had already received new coronavirus vaccine, but 10 residents (1.0%) were still hesitant to get vaccinated. According to the logistic regression analysis, believing that the vaccine is effective against COVID-19 (OR=0.507, 95%CI 0.278-0.924), believing that the personal protection can prevent COVID-19 (OR=1.610, 95%CI 1.012-2.563), believing no need for vaccination because the domestic risk is not high (OR=1.846, 95%CI 1.052-3.241), believing no need for vaccination because the treatment is perfect (OR=2.734, 95%CI 1.594-4.690), believing that vaccines are risky (OR=3.831, 95%CI 2.230-6.581), considering the underlying diseases (OR=4.148, 95%CI 2.554-6.735), worrying about the side effects of vaccine (OR=4.694, 95%CI 2.742-8.034), worrying about fake or expired vaccines (OR=2.191, 95%CI 1.206-3.981), fear of improper operation of vaccination personnel (OR=2.290, 95%CI 1.295-4.051), believing that the vaccine is safe but ineffective (OR=2.742, 95%CI 1.371-5.483), and not knowing where to get vaccinated (OR=1.772, 95%CI 1.118-2.807) were all risk factors for residents' hesitation in new coronavirus vaccine vaccination (all P<0.05). Conclusions　Solving the influencing factors of vaccine hesitation, enhancing people's awareness on vaccines, and increasing the vaccination coverage are the key to achieving herd immunity and the ultimate way to eliminate the epidemic. The epidemic prevention and control is good, and the investigation on the factors affecting vaccine hesitation has a certain reference value for the prevention work in rural areas.

Key words: COVID-19, Vaccination rate, Vaccination hesitation, Influencing factor

摘要： 目的　了解广西柳州农村地区居民对新型冠状病毒疫苗（新冠疫苗）的接种率、犹豫率及其影响因素，为提高疫苗覆盖率提供参考。方法　于2021年10月10日至2021年11月10日通过问卷星的方式对广西柳州农村地区居民进行问卷调查，分析广西柳州农村地区居民新冠疫苗接种及犹豫情况，并对人口学资料进行单因素分析，对于影响疫苗犹豫的相关因素进行多因素logistic回归分析，优势比（OR）>1和95%置信区间（95%CI）>1为疫苗犹豫的危险因素。计数资料使用χ²检验。结果　本次调查共收到1 033份问卷，1 033名调查对象中男532人（51.5%）、女501人（48.5%），年龄（55.2±18.7）岁。在广西柳州的疫苗接种及犹豫调查的1 033名居民中，1 023名（99.0%）居民已经接种新冠疫苗，但仍有10名（1.0%）居民对于接种新冠疫苗犹豫不决。通过logistic回归分析可知，认为疫苗能有效避免新冠病毒（OR=0.507，95%CI 0.278～0.924）、认为个人防护可避免新冠肺炎（OR=1.610，95%CI 1.012～2.563）、认为国内风险不高无需接种（OR=1.846，95%CI 1.052～3.241）、认为治疗手段完善无需接种（OR=2.734，95%CI 1.594～4.690）、认为疫苗存在风险（OR=3.831，95%CI 2.230～6.581）、认为身体有基础疾病（OR=4.148，95%CI 2.554～6.735）、担心疫苗副作用（OR=4.694，95%CI 2.742～8.034）、担心疫苗是假冒伪劣或过期产品（OR=2.191，95%CI 1.206～3.981）、担心疫苗接种人员操作不规范（OR=2.290，95%CI 1.295～4.051）、认为疫苗是安全的但有效性不高（OR=2.742，95%CI 1.371～5.483）、不知道去哪里接种（OR=1.772，95%CI 1.118～2.807）均是导致居民新冠疫苗接种犹豫的危险因素（均P<0.05）。结论　解决疫苗犹豫的影响因素，增强人们对于疫苗的认知，提高疫苗接种率，是实现群体免疫的关键，也是消灭这一流行病的最终方法。疫情防控良好，疫苗犹豫影响因素的调查对农村地区的预防工作具有一定的参考作用。

关键词: 新型冠状病毒肺炎, 疫苗接种率, 疫苗犹豫, 影响因素

Li Yinxi, Chen Lu, Lukatie , Li Zhi, Lyu Jiachun. Investigation on new coronavirus vaccine vaccination situation and hesitation and analysis of influencing factors in rural areas of Liuzhou, Guangxi[J]. International Medicine and Health Guidance News, 2022, 28(12): 1758-1763.

黎银曦, 陈璐, Lukatie, 李智, 吕嘉春. 广西柳州农村地区新型冠状病毒疫苗接种情况和犹豫性调查及其影响因素分析[J]. 国际医药卫生导报, 2022, 28(12): 1758-1763.

References

[1] Yamey G, Schäferhoff M, Hatchett R, et al. Ensuring global access to COVID-19 vaccines[J]. Lancet, 2020, 395(10234): 1405-1406. DOI: 10.1016/S0140-6736(20)30763-7.

[2] Luyten J, Beutels P. The social value of vaccination programs: beyond cost-effectiveness[J]. Health Aff(Millwood), 2016, 35(2):212-218. DOI: 10.1377/hlthaff.2015.1088.

[3] Wang C, Han B, Zhao T, et al. Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: a national cross-sectional study[J]. Vaccine, 2021. 39(21):2833-2842. DOI: 10.1016/j.vaccine.2021.04.020.

[4] Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19[J]. Eur J Epidemiol, 2020,35(4):325-330. DOI: 10.1007/s10654-020-00634-3.

[5] Omer SB, Salmon DA, Orenstein WA, et al. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases[J]. N Engl J Med, 2009, 360(19):1981-1988. DOI: 10.1056/NEJMsa0806477.

[6] Karafillakis E, Larson HJ, ADVANCE consortium. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations[J]. Vaccine, 2017, 35(37):4840-4850. DOI: 10.1016/j.vaccine.2017.07.061.

[7] Olive JK, Hotez PJ, Damania A, et al. The state of the antivaccine movement in the United States: a focused examination of nonmedical exemptions in states and counties[J]. PLoS Med, 2018, 15(6): e1002578. DOI: 10.1371/journal.pmed.1002578.

[8] Schuster M, Eskola J, Duclos P, et al. Review of vaccine hesitancy: rationale, remit and methods[J]. Vaccine, 2015, 33(34):4157-4160. DOI: 10.1016/j.vaccine.2015. 04.035.

[9] MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants[J]. Vaccine, 2015, 33(34):4161-4164. DOI: 10.1016/j.vaccine.2015.04.036.

[10] Domek GJ, O'Leary ST, Bull S, et al. Measuring vaccine hesitancy: field testing the WHO SAGE working group on vaccine hesitancy survey tool in Guatemala[J]. Vaccine, 2018, 36(35):5273-5281. DOI: 10.1016/j.vaccine.2018. 07.046.

[11] Geoghegan S, O'Callaghan KP, Offit PA. Vaccine safety: myths and misinformation[J]. Front Microbiol, 2020, 11:372. DOI: 10.3389/fmicb.2020.00372.

[12] Lurie N, Saville M, Hatchett R, et al. Developing COVID-19 vaccines at pandemic speed[J]. N Engl J Med, 2020, 382(21):1969-1973. DOI: 10.1056/NEJMp2005630.

[13] Yang Y, Peng F, Wang R, et al. The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China[J]. J Autoimmun, 2020, 109: 102434. DOI: 10.1016/j.jaut.2020.102434.

[14] Hardt K, Bonanni P, King S, et al. Vaccine strategies: optimising outcomes[J]. Vaccine. 2016, 34(52):6691-6699. DOI: 10.1016/j.vaccine.2016.10.078.

[15] Xiao X, Wong RM. Vaccine hesitancy and perceived behavioral control: a meta-analysis[J]. Vaccine, 2020, 38(33):5131-5138. DOI: 10.1016/j.vaccine.2020.04.076.

[16] Rodríguez-Blanco N, Montero-Navarro S, Botella-Rico JM, et al. Willingness to be vaccinated against COVID-19 in Spain before the start of vaccination: a cross-sectional study[J]. Int J Environ Res Public Health, 2021, 18(10): 5272. DOI: 10.3390/ijerph18105272.

[17] Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan[J]. Vaccines (Basel), 2021, 9(1):48. DOI: 10.3390/vaccines9010048.

[18] Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia[J]. BMC Public Health, 2021, 21(1): 1438. DOI: 10.1186/s12889-021-11501-5.

[19] Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine[J]. Nat Med, 2021, 27(2): 225-228. DOI: 10.1038/s41591-020-1124-9.

[20] Callaghan T, Moghtaderi A, Lueck JA, et al. Correlates and disparities of intention to vaccinate against COVID-19[J]. Soc Sci Med. 2021, 272:113638. DOI: 10.1016/j.socscimed.2020.113638.

[21] Tian H, Liu Y, Li Y, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China[J]. Science, 2020, 368(6491): 638-642. DOI: 10.1126/science.abb6105.

[22] Leung K, Wu JT, Liu D, et al. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment[J]. Lancet, 2020, 395(10233): 1382-1393. DOI: 10.1016/S0140-6736(20)30746-7.

[23] Omar DI, Hani BM. Attitudes and intentions towards COVID-19 vaccines and associated factors among Egyptian adults[J]. J Infect Public Health, 2021, 14(10): 1481-1488. DOI: 10.1016/j.jiph.2021.06.019.

[24] Kreps S, Prasad S, Brownstein JS, et al. Factors associated with US Adults' likelihood of accepting COVID-19 vaccination[J]. JAMA Netw Open, 2020, 3(10): e2025594. DOI: 10.1001/jamanetworkopen.2020.25594.

[25] Tu S, Sun FY, Chantler T, et al. Caregiver and service provider vaccine confidence following the Changchun Changsheng vaccine incident in China: a cross-sectional mixed methods study[J]. Vaccine, 2020, 38(44): 6882-6888. DOI: 10.1016/j.vaccine.2020.08.063.

[26] Larson HJ, Jarrett C, Eckersberger E, et al. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012[J]. Vaccine, 2014, 32(19): 2150-2159. DOI: 10.1016/j.vaccine.2014.01.081.

[27] Gust DA, Kennedy A, Shui I, et al. Parent attitudes toward immunizations and healthcare providers the role of information[J]. Am J Prev Med, 2005, 29(2): 105-112. DOI: 10.1016/j.amepre.2005.04.010.

[28] Kraemer MUG, Yang CH, Gutierrez B, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China[J]. Science, 2020, 368(6490): 493-497. DOI: 10.1126/science.abb4218.

[29] Dubé E, Gagnon D, Zhou Z, et al. Parental vaccine hesitancy in quebec (Canada)[J]. PLoS Curr, 2016, 8: 9e239605f4d320c6ad27ce2aea5aaad2. DOI: 10.1371/currents.outbreaks.9e239605f4d320c6ad27ce2aea5aaad2.

Investigation on new coronavirus vaccine vaccination situation and hesitation and analysis of influencing factors in rural areas of Liuzhou, Guangxi

广西柳州农村地区新型冠状病毒疫苗接种情况和犹豫性调查及其影响因素分析

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 13

Recommended Articles

Metrics

[1]	Dai Xiaoli, Yang Yixiang. IgM detection results of antibodies against respiratory pathogens before and after COVID-19 at Songjiang District, Shanghai [J]. International Medicine and Health Guidance News, 2022, 28(9): 1260-1263.
[2]	Xie Xiaobo, Yu Dexian, Liu Wenyi, Yang Yang. Immunogenicity and influencing factors of measles-mumps-rubella combined vaccine and cognition of vaccination in recruits [J]. International Medicine and Health Guidance News, 2022, 28(8): 1093-1098.
[3]	Zhang Na, Wei Wei, Xu Xinke, Chen Cheng, Sun Guifang, Tan Yonghong. Risk factors of intraoperative massive hemorrhage in children undergoing brain tumor removal [J]. International Medicine and Health Guidance News, 2022, 28(8): 1099-1103.
[4]	Zhao Yang, Zhou Jie, Geng Zhaohui. Research progress on evaluation and risk factors of cognitive frailty in hypertensive patients [J]. International Medicine and Health Guidance News, 2022, 28(6): 748-752.
[5]	Xie Sumei, Chen Hui, Chen Zhongying, Wen Qi, Liu Ting, Li Kun, Wang Tong. A mixed study on current status of sexual health needs of spinal cord injury patients based on an anthropological perspective and influencing factors [J]. International Medicine and Health Guidance News, 2022, 28(5): 651-655.
[6]	Xu Wanzhu, Luo Zebin, Chen Chujun, Wang Peiru, Hong Lichun. Status and influencing factors of discharge readiness in cancer patients [J]. International Medicine and Health Guidance News, 2022, 28(5): 734-739.
[7]	Li Kexin, Huang Meiling, Jiang Ziyan, Cai Yixiang. Investigation and analysis of current situation of high-risk early warning assessment ability for midwives in Guangzhou [J]. International Medicine and Health Guidance News, 2022, 28(4): 500-504.
[8]	Liu Yu, Xu Jianying, Deng Lili, Guan Lijuan, Li Jianji, Lin Jingxia, Wu Qiaomei, Yang Liming. Experience of construction and nursing management of transitional wards under emergency situation in epidemic closed and controlled areas in Guangzhou [J]. International Medicine and Health Guidance News, 2022, 28(4): 516-519.
[9]	Cao Ying, Yang Liming, Lin Jingxia, Liu Yu, Zhang Xiaochun, Yang Yanting, Deng Lili. Risk identification and hierarchical management strategies of patients in comprehensive isolation ward of epidemic closed and controlled areas in Guangzhou [J]. International Medicine and Health Guidance News, 2022, 28(4): 520-522.
[10]	Ou Youliang, Zhang Jun, Zhou Yanli, Xiao Chaoqun, Wu Yuyu, Du Pingping. Application effect of Family Assessment Device in pre-examination triage of pregnant women's psychological state during the epidemic [J]. International Medicine and Health Guidance News, 2022, 28(13): 1820-1824.
[11]	Zhang Xueli, Xu Yanjie, Ma Ping. Catheter maintenance KAP and its influencing factors among primary caregivers for 6-12 years old children with ALL undergoing PICC catheterization [J]. International Medicine and Health Guidance News, 2022, 28(10): 1352-1356.
[12]	Jiang Baoe, Jiang Wenting. Analysis of influencing factors and improvement measures of "missing the optimal time window for thrombolysis" in patients with acute ischemic stroke [J]. International Medicine and Health Guidance News, 2021, 27(6): 897-900.
[13]	Ma Weiwei. Analysis of humanistic care needs and influencing factors of elderly patients with primary liver cancer undergoing interventional therapy [J]. International Medicine and Health Guidance News, 2021, 27(6): 901-904.